Skip to main content

Therapeutics Startups

Updated July 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,708
Total Funding
$1.4B
Avg Funding
$57.4M
Global Reach
8
countries

Top Cities for Therapeutics

Cambridge
Dallas
Copenhagen
San Francisco
South San Francisco
Yokohama

Recently Funded Companies

Export
Cambridge, United States

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

$25.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Dallas, United States

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

$18.4M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Cambridge, United States

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

$155.3M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

Blue Cell Therapeutics is a biotechnology company developing novel stem cell therapies to cure chronic diseases.

$1.5M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

$31.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Forta is a provider of healthcare services to help children with autism.

$55.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

$100.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

$250.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Yokohama, Japan

Aikomi is a mental healthcare company that uses AI-driven digital therapy care treatments to alleviate dementia.

$602K raised
Oct 2024

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery.

$875K raised
Oct 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.

$10.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Watertown, United States

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

$225.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

$250.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Paris, France

Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies.

$1.6M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Blackrock, Ireland

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

$21.5M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Franklin, United States

CASS Pharmaceuticals is a medical company that provides rapid-acting insulin for diabetic patients.

$2.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .

$43.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Brisbane, Australia

Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.

$1.3M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Washington, United States

Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company

$20.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Morristown, United States

Neumentum is a neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.

$16.6M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Natick, United States

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

$35.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

$42.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Philadelphia, United States

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

$33.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Ecublens, Switzerland

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

$35.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

San Jose, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

$60.3M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Showing 1651 to 1675 of 1,708 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.

Average Funding
$57.4M
Total Funding Tracked
$1.4B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
4 companies$315.9M
2.Cambridge
3 companies$211.3M
3.South San Francisco
2 companies$350.0M
4.Dallas
1 companies$18.4M
5.Copenhagen
1 companies$1.5M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,708 Therapeutics Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 67 | VCBacked